Case File
efta-efta00870566DOJ Data Set 9OtherFrom: Jeffrey Epstein <jeevacationggmail.com>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00870566
Pages
4
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <jeevacationggmail.com>
To: Tazia Smith
Subject: Re: Fw: Paylocity IPO
Date: Mon, 17 Mar 2014 18:11:13 +0000
yes as much as possible for all ipos standing order thanks
On Mon, Mar 17, 2014 at 11:58 AM, Tazia Smith <
wrote:
Jeffrey - Please confirm whether or not you have interest in Paylocity -
Thanks,
Tazia
— Forwarded by Tazia Smith/db/dbcom on 03/17/2014 01:48 PM
From:
Tazia Srnith/db/dbcom
To:
[email protected],
Cc:
Paul Melts
03/14/2014 03:59 PM
Subject: Paylocity IPO
Jeffrey -
Paylocity (—$100mm IPO) books closing Monday. Let's discuss when you have a moment.
Thanks,
Tazia
FORV, rind lw T,71, Smithiellifelhrnrn nn ni/14/2014 12:51 PM --
From:
To.
03/07/2014 06:55 AM
Subject: ••• NEW LEFT BOOKRUN IPO '" PAYLOCITY HOLDING CORP (NASDAQ: PCTY) "' APPROVED FOR EXTERNAL DISTRIBUTION •••
*** APPROVED FOR EXTERNAL DISTRIBUTION ***
Issuer: Paylocity Holding Corp
Symbol: PCTY
EFTA00870566
Deal size: 6,670,000 shares (75% primary / 25% secondary) plus 15% greenshoe (37% primary / 63%
secondary)
Offer range: $14.00 - 16.00
Exchange: Nasdaq
Anticipated pricing: Tuesday, March 18th
Business description:
Paylocity is a cloud-based provider of payroll and human capital management, or HCM, software solutions for
medium-sized organizations, which are defined as those having between 20 and 1,000 employees. Paylocity's
comprehensive and easy-to-use solutions enable its clients to manage their workforces more effectively. As of
June 30, 2013, Paylocity served approximately 6,850 clients across the U.S., which on average had over 100
employees. Paylocity's solutions help drive strategic human capital decision-making and improve employee
engagement by enhancing the human resource, payroll and finance capabilities of its clients.
Roadshow:
3/7 — Launch / New York
3/10 — New York
3/11 — Boston
3/12 — New York (Lunch)
3/13 — Mid Atlantic (BAML)
3/14 — Den (DB) / LA (BAML)
3/17 —San Francisco (DB)
3/18 — Midwest (WBlair)
Lunch details:
Group Lunch — New York
March 12, 2014 @ 12:30pm
The St. Regis New York
Room: "La Maisonette"
Group Lunch — Boston
March 11, 2014 @ 12:30 pm
The Langham, Boston
EFTA00870567
Room: Wilson Ballroom "A"
Bookrunners:
Deutsche Bank
BAML
William Blair
Co-managers:
Raymond James
JMP
Needham
The issuer has filed a registration statement (including a prospectus) with the SEC for
the offering to which this communication relates. Before you invest, you should read
the prospectus in that registration statement and other documents the issuer has filed
with the SEC for more complete information about the issuer and this offering. You may
get these documents for free by visiting EDGAR on the SEC Web site, at www.sec.gov.
Alternatively, the issuer, any underwriter or any dealer participating in the offering will
arrange to send you the prospectus if you request it by calling toll-free 1-800-503-4611
or by mail from Deutsche Bank Securities Inc., 60 Wall Street, New York, New York
10016, or by email at
This communication may contain confidential and/or privileged information.
If you are not the intended recipient (or have received this communication
in error) please notify the sender immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the
material in this communication is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
EFTA00870568
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00870569
Technical Artifacts (5)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
jeevacationggmail.comDomain
www.sec.govEmail
[email protected]Email
[email protected]Phone
1-800-503-4611Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.